Large-Volume Drainage of Malignant Pleural Effusions: Risks and Benefits

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 345A
Author(s):  
Alan D. Sihoe ◽  
Nicholson Yam
Lab on a Chip ◽  
2022 ◽  
Author(s):  
Nan Xiang ◽  
Zhonghua Ni

On-chip concentration of rare malignant tumor cells (MTCs) in malignant pleural effusions (MPEs) with a large volume is challenging. Previous microfluidic concentrators suffer from a low concentration factor (CF) and...


Author(s):  
Prado Victor E ◽  
Chen Shasha X ◽  
Sukhal Shashvat ◽  
Smith Sean B ◽  
Patel Sanjay A

Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. S94-S95
Author(s):  
T. Patrick ◽  
S. Voller ◽  
C. Wells ◽  
P. Molangiri ◽  
H. Hatchett-Cole ◽  
...  

2020 ◽  
Vol 37 (04) ◽  
pp. 434-440
Author(s):  
James Jeffries ◽  
Matthew Gayed ◽  
Thuong G. Van Ha ◽  
Rakesh Navuluri

2021 ◽  
Vol 1 (2) ◽  
pp. 98-104
Author(s):  
Avinash Aujayeb ◽  
Donna Wakefield

Introduction: Cancer-related fatigue is well described. Fatigue in patients with a malignant pleural effusion (MPE) has not been directly studied. Methods: A prospective observational cohort pilot study ‘Do Interventions for Malignant Pleural Effusions (MPE) impact on patient reported fatigue levels (IMPE-F study)’ is planned to determine whether pleural interventions reduce fatigue in MPE. Fatigue will be assessed with a validated patient reported outcome measure, FACIT-F. Discussion: MPE-F has funding from Rocket Medical Plc, and is part of a Masters in Clinical Research at Newcastle University. Respondent fatigue will be addressed by the investigators going through the questionnaire with the participants. Inclusion criteria are all patients above 18 years of age with a presumed MPE undergoing a procedure and able to consent. The expected number of participants is 50. Trial registration: The IMPE-F study has Research Ethics Committee (REC) [20/YH/0224] and Health Research Authority (HRA) and Health and Care Research Wales (HCRW) approvals [IRAS project ID: 276451]. The study has been adopted on National Institute for Health Research portfolio [CPMS ID 46430].


2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Jia-Xi Li ◽  
Yan-Mei Shi ◽  
Li-Ya An ◽  
Jin-Xu Yang ◽  
Yu-Xing Qi ◽  
...  

Abstract Objectives To fully assess the quality of the guidelines for the management of malignant pleural effusions (MPE) and ascites and reveal the heterogeneity of recommendations and possible reasons among guidelines. Methods A systematic search was performed in the database to obtain guidelines for the management of MPE and ascites. The AGREE IIGtool was used to assess the quality of these guidelines. The Measurement Scale of Rate of Agreement (MSRA) was introduced to assess the scientific agreement of formulated recommendations for the management of MPE and ascites among guidelines, and evidence supporting these recommendations was extracted and analyzed. Results Nine guidelines were identified. Only 4 guidelines scored more than 60% and are worth recommending. Recommendations were also heterogeneous among guidelines for the management of MPE, and the main reasons were the different emphases of the recommendations for the treatment of MPE, the contradictions in recommendations, and the unreasonably cited evidence for MPE. Conclusions The quality of the management guidelines for patients with MPE and malignant ascites was highly variable. Specific improvement of the factors leading to the heterogeneity of recommendations will be a reasonable and effective way for developers to upgrade the recommendations in the guidelines for MPE.


Lung Cancer ◽  
2020 ◽  
Vol 139 ◽  
pp. S83
Author(s):  
R. Punwani ◽  
P. Isola ◽  
J. Graves ◽  
D. Edwards ◽  
A. Grey ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document